Mkts

GeneDx Holdings Corp.

NASDAQ: WGS
$49.48-2.39 (-4.61%)
As of Nov 13, 10:58 AM ET

Key statistics

Day range
48.6751.74
52-week range
32.21170.87
Today
Open51.42
Previous close49.48
Volume2.4K
Valuation
Market cap1.63B
P/E ratio—
EPS (TTM)-3.63
Income & risk
Dividend / yield—
Beta2.16
Avg volume800.1K
Discussion

WGS News

Stories mentioning WGS from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue102,254120,989116,743102,69287,11595,64076,87470,514
Cost of Goods Sold34,04336,72132,21631,79028,63929,43529,04527,562
Gross Profit68,21184,26884,52770,90258,47666,20547,82942,952
Operating Expenses
Research & Development19,80424,54119,82915,07912,57711,58811,66510,902
Sales General & Admin74,59150,450
Total Operating Expenses
Operating Income (Loss)(57,471)(14,235)(3,251)8,960(4,551)8,806(7,780)(10,579)
Interest Income
Interest Expense
Other Expense(206.00)(4,591)(174.00)239.00209.00(714.00)1,144(13,481)
Pretax Income(62,419)(18,230)(7,388)10,563(6,082)5,414(8,359)(29,363)
Tax Provision897.00(564.00)247.00(246.00)447.00(24.00)(47.00)(190.00)
Net Income (Loss)(63,316)(17,666)(7,635)10,809(6,529)5,438(8,312)(29,173)
Earnings Per Share (Basic)(2.16)(0.62)(0.27)0.38(0.23)0.20(0.31)(1.10)
Earnings Per Share (Diluted)(2.16)(0.62)(0.27)0.36(0.23)0.20(0.31)(1.10)
Weighted Average Shares Outstanding (Basic)29,33528,64228,79828,58028,14826,89127,09626,618
Weighted Average Shares Outstanding (Diluted)29,33528,64228,79829,75428,14826,89127,09626,618

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About WGS

GeneDx Holdings Corp. (NASDAQ: WGS) is a stock listed on the Nasdaq Stock Market under the ticker symbol WGS. It last traded at $49.48 (Nov 13, 2026, 10:58 AM ET), down 4.6% on the day. That gives GeneDx a market capitalisation of $1.6B.

Over the past 52 weeks WGS has traded between $32.21 and $170.87.

Revenue for the quarter ended Mar 31, 2026 was $102.3M; a net loss of $63.3M. Revenue was up 17.4% from $87.1M in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$102.3M-$63.3M-61.9%
Dec 31, 2025$121.0M-$17.7M-14.6%
Sep 30, 2025$116.7M-$7.6M-6.5%
Jun 30, 2025$102.7M$10.8M10.5%

From GeneDx’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…